- Home
- OSS vs PLX Comparison
OSS vs PLX Comparison
Compare OSS & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSS
- PLX
- Stock Information
- Founded
- OSS 1998
- PLX 1993
- Country
- OSS United States
- PLX United States
- Employees
- OSS N/A
- PLX N/A
- Industry
- OSS Computer Manufacturing
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OSS Technology
- PLX Health Care
- Exchange
- OSS Nasdaq
- PLX Nasdaq
- Market Cap
- OSS 109.5M
- PLX 127.4M
- IPO Year
- OSS 2018
- PLX 1998
- Fundamental
- Price
- OSS $5.37
- PLX $1.48
- Analyst Decision
- OSS
- PLX Strong Buy
- Analyst Count
- OSS 0
- PLX 1
- Target Price
- OSS N/A
- PLX $15.00
- AVG Volume (30 Days)
- OSS 592.7K
- PLX 616.7K
- Earning Date
- OSS 08-07-2025
- PLX 08-13-2025
- Dividend Yield
- OSS N/A
- PLX N/A
- EPS Growth
- OSS N/A
- PLX N/A
- EPS
- OSS N/A
- PLX 0.05
- Revenue
- OSS $54,301,661.00
- PLX $59,764,000.00
- Revenue This Year
- OSS $8.73
- PLX $65.02
- Revenue Next Year
- OSS $12.37
- PLX $57.34
- P/E Ratio
- OSS N/A
- PLX $31.04
- Revenue Growth
- OSS N/A
- PLX 0.18
- 52 Week Low
- OSS $1.82
- PLX $0.82
- 52 Week High
- OSS $6.40
- PLX $3.10
- Technical
- Relative Strength Index (RSI)
- OSS 58.35
- PLX 50.31
- Support Level
- OSS $5.00
- PLX $1.46
- Resistance Level
- OSS $5.57
- PLX $1.53
- Average True Range (ATR)
- OSS 0.45
- PLX 0.06
- MACD
- OSS -0.08
- PLX 0.01
- Stochastic Oscillator
- OSS 44.90
- PLX 57.14
About OSS One Stop Systems Inc.
One Stop Systems Inc designs, manufactures, and markets specialized rugged high-performance compute ("HPC"), high-speed switch fabrics, and storage systems, which are designed to target edge applications for artificial intelligence ("AI") / machine learning ("ML"), sensor processing, sensor fusion, and autonomy. The company operates in two reportable segments; OSS designs and manufactures high-performance customized computers and flash arrays, in-flight entertainment & connectivity. Bressner operates as a system integrator with standard and custom all-in-one hardware systems and components for many kinds of industrial environments. The company generates the majority of its revenue from the Bressner segment.
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.